Abstract
In this small pilot study, anti-Müllerian hormone (AMH) levels in women undergoing chemotherapy and hematopoietic stem cell transplantation facilitated earlier identification of impaired ovarian reserve compared with FSH and the resumption of menses. Larger studies are needed to accurately assess the clinical significance of AMH levels in the prediction of long-term reproductive outcomes in reproductive-age transplant patients with our current conditioning regimen.
Original language | English (US) |
---|---|
Pages (from-to) | 1529-1532 |
Number of pages | 4 |
Journal | Fertility and sterility |
Volume | 91 |
Issue number | 4 SUPPL. |
DOIs | |
State | Published - Apr 2009 |
Externally published | Yes |
Keywords
- Stem cell transplant
- anti-Müllerian hormone
- ovarian reserve
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology